Showing results (191-200 of 202) with videos related to
Sort By:
Pageof 21
The Journal of Biological Chemistry|March 10, 1995
Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64T S Juan, E Hailman, M J Kelley, et al.Biochimica Et Biophysica Acta|July 21, 2000
A target for cholesterol absorption inhibitors in the enterocyte brush border membraneP A Detmers, S Patel, M Hernandez, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1983
Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodiesS D Wright, P E Rao, W C Van Voorhis, et al.Biochemical and Biophysical Research Communications|August 4, 2001
ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5S Patel, E M Thelander, M Hernandez, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivoR Thieringer, J E Fenyk-Melody, C B Le Grand, et al.The Journal of Biological Chemistry|July 8, 1994
Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene familyH S Lichenstein, D E Lyons, M M Wurfel, et al.The Journal of Experimental Medicine|February 12, 1998
Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intactM M Wurfel, B G Monks, R R Ingalls, et al.The Journal of Experimental Medicine|April 19, 2000
Infectious agents are not necessary for murine atherogenesisS D Wright, C Burton, M Hernandez, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 9, 2001
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol loweringC P Sparrow, C A Burton, M Hernandez, et al.Biochemical and Biophysical Research Communications|December 19, 2000
PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liverA Hermanowski-Vosatka, D Gerhold, S S Mundt, et al.Pageof 21